A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Verastem, Inc.
Servier
Pfizer
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Actuate Therapeutics Inc.
Merck Sharp & Dohme LLC
Pfizer
Hoffmann-La Roche
Trishula Therapeutics, Inc.
EpicentRx, Inc.
BeiGene
Galvanize Therapeutics, Inc.
Coherus Oncology, Inc.
Incyte Corporation
CTI BioPharma
Eli Lilly and Company
Eli Lilly and Company
Incyte Corporation
Celgene
Sanofi
Shenzhen Hornetcorn Bio-technology Company, LTD
Jiangsu Simcere Pharmaceutical Co., Ltd.
Amgen
Amgen
Spectrum Pharmaceuticals, Inc
Pfizer
Pfizer
Pfizer
Eli Lilly and Company
Sanofi
Sanofi
AstraZeneca
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company